• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新兴的 FLiRT 变体挑战:大流行格局中的 KP.1.1 和 KP.2。

The emerging challenge of FLiRT variants: KP.1.1 and KP.2 in the global pandemic landscape.

机构信息

Center for One Health, Global Center for Evidence Synthesis, Chandigarh, India.

Graphic Era (Deemed to be University), Clement Town, India.

出版信息

QJM. 2024 Jul 1;117(7):485-487. doi: 10.1093/qjmed/hcae102.

DOI:10.1093/qjmed/hcae102
PMID:38867702
Abstract

The SARS-CoV-2 virus has undergone substantial evolution, leading to emergence of new FLiRT variants characterized by specific spike mutations-F to L at position 456 and R to T at position 346-enhancing their transmissibility and immune evasion capabilities. Particularly, KP.2 shows a significant increase in cases in the USA, indicating a potential shift in the pandemic landscape due to its greater ability to evade vaccine-induced immunity and its higher effective reproduction number compared to JN.1. This evolving scenario underscores the need for continuous monitoring and adaptive response strategies to address the challenges posed by these new variants. This abstract examines the emergence of FLiRT variants KP.2 and KP1.1, descendants of the Omicron JN.1 variant, as they draw global attention amidst the ongoing coronavirus disease-2019 pandemic.

摘要

SARS-CoV-2 病毒经历了大量进化,出现了新的 FLiRT 变体,其特征是刺突蛋白特定突变-F 到 L 位于位置 456 和 R 到 T 位于位置 346,增强了它们的传染性和免疫逃避能力。特别是,KP.2 在 美国的病例显著增加,表明由于其逃避疫苗诱导的免疫能力更强,以及与 JN.1 相比更高的有效繁殖数,大流行格局可能发生变化。这种不断演变的情况突显了需要持续监测和适应性应对策略来应对这些新变体带来的挑战。本文研究了 Omicron JN.1 变体的后代 FLiRT 变体 KP.2 和 KP1.1 的出现,因为它们在持续的 2019 冠状病毒病大流行中引起了全球关注。

相似文献

1
The emerging challenge of FLiRT variants: KP.1.1 and KP.2 in the global pandemic landscape.新兴的 FLiRT 变体挑战:大流行格局中的 KP.1.1 和 KP.2。
QJM. 2024 Jul 1;117(7):485-487. doi: 10.1093/qjmed/hcae102.
2
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.新型冠状病毒XEC变异株N端结构域糖基化突变在免疫逃逸、细胞间融合及刺突蛋白稳定性中的作用
J Virol. 2025 Apr 15;99(4):e0024225. doi: 10.1128/jvi.00242-25. Epub 2025 Mar 26.
3
Decoding omicron: Genetic insight into its transmission dynamics, severity spectrum and ever-evolving strategies of immune escape in comparison with other SARS-CoV-2 variants.解读奥密克戎:与其他新冠病毒变体相比,对其传播动态、严重程度范围及不断演变的免疫逃逸策略的遗传学见解
Diagn Microbiol Infect Dis. 2025 Mar;111(3):116705. doi: 10.1016/j.diagmicrobio.2025.116705. Epub 2025 Jan 23.
4
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.AlphaFold2 对 SARS-CoV-2 刺突奥密克戎 JN.1、KP.2 和 KP.3 变体构象集合的建模和分子动力学模拟:结合能突变分析揭示 ACE2 亲和力的上位驱动因素和抗体耐药性逃逸热点。
Viruses. 2024 Sep 13;16(9):1458. doi: 10.3390/v16091458.
5
Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients.奥密克戎变种JN.1、KP.2和KP.3对新冠康复者及疫苗接种者的多克隆和单克隆抗体的免疫逃逸
Antiviral Res. 2025 Mar;235:106092. doi: 10.1016/j.antiviral.2025.106092. Epub 2025 Jan 27.
6
JN.1 variant in enduring COVID-19 pandemic: is it a variety of interest (VoI) or variety of concern (VoC)?JN.1 变异株与持续的 COVID-19 大流行:它是一种利益变异株(VoI)还是一种关注变异株(VoC)?
Horm Mol Biol Clin Investig. 2024 Apr 17;45(2):49-53. doi: 10.1515/hmbci-2023-0088. eCollection 2024 Jun 1.
7
Investigating the FLiRT variants of COVID-19: Is it an emerging concern?调查 COVID-19 的 FLiRT 变体:这是一个新出现的问题吗?
Pathol Res Pract. 2024 Oct;262:155542. doi: 10.1016/j.prp.2024.155542. Epub 2024 Aug 13.
8
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)从XBB到JN.1抗原性转变的抗体反应演变
Nature. 2025 Jan;637(8047):921-929. doi: 10.1038/s41586-024-08315-x. Epub 2024 Nov 7.
9
Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants.JN.1 衍生的 SARS-CoV-2 SLip、FLiRT 和 KP.2 变体的中和逃逸、感染性和膜融合。
Cell Rep. 2024 Aug 27;43(8):114520. doi: 10.1016/j.celrep.2024.114520. Epub 2024 Jul 17.
10
Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global Impact.奥密克戎亚型的综合分析:例如,EG.5 崛起、疫苗接种策略和全球影响。
Curr Drug Targets. 2024;25(8):517-525. doi: 10.2174/0113894501296586240430061915.

引用本文的文献

1
Comparable immune escape capacity between KP.2 and other SARS-CoV-2 variants in the central Chinese population after the first COVID-19 booster.在中国中部人群中,首次接种新冠疫苗加强针后,KP.2与其他新冠病毒变异株之间具有相当的免疫逃逸能力。
Sci Rep. 2025 May 22;15(1):17762. doi: 10.1038/s41598-025-02927-7.
2
Advances in Virus Biorecognition and Detection Techniques for the Surveillance and Prevention of Infectious Diseases.用于传染病监测与预防的病毒生物识别及检测技术进展
Biosensors (Basel). 2025 Mar 20;15(3):198. doi: 10.3390/bios15030198.
3
Daphnetin may protect from SARS-CoV-2 infection by reducing ACE2.
瑞香素可能通过降低血管紧张素转换酶2(ACE2)来预防新型冠状病毒(SARS-CoV-2)感染。
Sci Rep. 2024 Dec 28;14(1):30682. doi: 10.1038/s41598-024-79734-z.
4
The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets.抗精神病药物鲁拉西酮通过影响多个靶点来抑制冠状病毒。
Front Cell Infect Microbiol. 2024 Nov 25;14:1487604. doi: 10.3389/fcimb.2024.1487604. eCollection 2024.
5
Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变种的中和单克隆抗体(nMAbs)的治疗潜力
Curr Pharm Des. 2025;31(10):753-773. doi: 10.2174/0113816128334441241108050528.
6
Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders.利用深度自编码器的异常检测预测 SARS-CoV-2 谱系的优势度。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae535.
7
Emergence of SARS-CoV-2 variants KP.2 and KP.3 sparks concerns: What should we do?严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体KP.2和KP.3的出现引发担忧:我们该怎么办?
Health Care Sci. 2024 Aug 6;3(4):211-214. doi: 10.1002/hcs2.110. eCollection 2024 Aug.
8
Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders.使用深度自动编码器通过异常检测预测SARS-CoV-2谱系的优势地位。
bioRxiv. 2024 Sep 26:2023.10.24.563721. doi: 10.1101/2023.10.24.563721.